vs

Side-by-side financial comparison of Freshworks Inc. (FRSH) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $228.6M, roughly 1.2× Freshworks Inc.). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -2.1%, a 2.8% gap on every dollar of revenue. On growth, Freshworks Inc. posted the faster year-over-year revenue change (16.5% vs -16.5%).

Freshworks Inc. is a cloud-based software-as-a-service company, founded in 2010 in Chennai, India. The company provides cloud-based tools for customer relationship management (CRM), IT service management (ITSM), and e-commerce marketing.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

FRSH vs HCM — Head-to-Head

Bigger by revenue
HCM
HCM
1.2× larger
HCM
$270.8M
$228.6M
FRSH
Growing faster (revenue YoY)
FRSH
FRSH
+33.0% gap
FRSH
16.5%
-16.5%
HCM
Higher net margin
HCM
HCM
2.8% more per $
HCM
0.7%
-2.1%
FRSH

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FRSH
FRSH
HCM
HCM
Revenue
$228.6M
$270.8M
Net Profit
$-4.8M
$2.0M
Gross Margin
84.8%
37.7%
Operating Margin
11.6%
-13.2%
Net Margin
-2.1%
0.7%
Revenue YoY
16.5%
-16.5%
Net Profit YoY
-268.9%
-83.6%
EPS (diluted)
$-0.02
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRSH
FRSH
HCM
HCM
Q1 26
$228.6M
Q4 25
$222.7M
$270.8M
Q3 25
$215.1M
Q2 25
$204.7M
$277.7M
Q1 25
$196.3M
$324.5M
Q4 24
$194.6M
Q3 24
$186.6M
Q2 24
$174.1M
$305.7M
Net Profit
FRSH
FRSH
HCM
HCM
Q1 26
$-4.8M
Q4 25
$191.4M
$2.0M
Q3 25
$-4.7M
Q2 25
$-1.7M
$455.0M
Q1 25
$-1.3M
$11.9M
Q4 24
$-21.9M
Q3 24
$-30.0M
Q2 24
$-20.2M
$25.8M
Gross Margin
FRSH
FRSH
HCM
HCM
Q1 26
84.8%
Q4 25
85.6%
37.7%
Q3 25
84.7%
Q2 25
84.8%
0.1%
Q1 25
84.8%
48.0%
Q4 24
84.9%
Q3 24
84.0%
Q2 24
83.8%
41.1%
Operating Margin
FRSH
FRSH
HCM
HCM
Q1 26
11.6%
Q4 25
17.8%
-13.2%
Q3 25
-3.5%
Q2 25
-4.2%
-1.3%
Q1 25
-5.3%
-5.0%
Q4 24
-12.2%
Q3 24
-20.8%
Q2 24
-25.1%
-9.0%
Net Margin
FRSH
FRSH
HCM
HCM
Q1 26
-2.1%
Q4 25
86.0%
0.7%
Q3 25
-2.2%
Q2 25
-0.8%
163.8%
Q1 25
-0.7%
3.7%
Q4 24
-11.3%
Q3 24
-16.1%
Q2 24
-11.6%
8.4%
EPS (diluted)
FRSH
FRSH
HCM
HCM
Q1 26
$-0.02
Q4 25
$0.66
$0.00
Q3 25
$-0.02
Q2 25
$-0.01
$0.52
Q1 25
$0.00
$0.01
Q4 24
$-0.07
Q3 24
$-0.10
Q2 24
$-0.07
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRSH
FRSH
HCM
HCM
Cash + ST InvestmentsLiquidity on hand
$548.2M
$1.4B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.0B
$1.2B
Total Assets
$1.6B
$1.8B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRSH
FRSH
HCM
HCM
Q1 26
$548.2M
Q4 25
$781.4M
$1.4B
Q3 25
$813.2M
Q2 25
$926.2M
$1.4B
Q1 25
$995.3M
$836.1M
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.0B
$802.5M
Total Debt
FRSH
FRSH
HCM
HCM
Q1 26
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Stockholders' Equity
FRSH
FRSH
HCM
HCM
Q1 26
$1.0B
Q4 25
$1.0B
$1.2B
Q3 25
$851.5M
Q2 25
$984.6M
$1.2B
Q1 25
$1.1B
$759.9M
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.1B
$740.1M
Total Assets
FRSH
FRSH
HCM
HCM
Q1 26
$1.6B
Q4 25
$1.6B
$1.8B
Q3 25
$1.4B
Q2 25
$1.5B
$1.8B
Q1 25
$1.5B
$1.3B
Q4 24
$1.6B
Q3 24
$1.6B
Q2 24
$1.5B
$1.3B
Debt / Equity
FRSH
FRSH
HCM
HCM
Q1 26
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRSH
FRSH
HCM
HCM
Operating Cash FlowLast quarter
$62.4M
$8.2M
Free Cash FlowOCF − Capex
$3.4M
FCF MarginFCF / Revenue
1.2%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRSH
FRSH
HCM
HCM
Q1 26
$62.4M
Q4 25
$62.3M
$8.2M
Q3 25
$63.5M
Q2 25
$58.6M
$-72.9M
Q1 25
$58.0M
$40.3M
Q4 24
$41.4M
Q3 24
$42.3M
Q2 24
$36.3M
$-39.8M
Free Cash Flow
FRSH
FRSH
HCM
HCM
Q1 26
Q4 25
$60.1M
$3.4M
Q3 25
$61.7M
Q2 25
$58.2M
$-82.2M
Q1 25
$56.7M
$32.5M
Q4 24
$36.3M
Q3 24
$41.3M
Q2 24
$34.0M
$-49.9M
FCF Margin
FRSH
FRSH
HCM
HCM
Q1 26
Q4 25
27.0%
1.2%
Q3 25
28.7%
Q2 25
28.4%
-29.6%
Q1 25
28.9%
10.0%
Q4 24
18.7%
Q3 24
22.1%
Q2 24
19.5%
-16.3%
Capex Intensity
FRSH
FRSH
HCM
HCM
Q1 26
Q4 25
1.0%
1.8%
Q3 25
0.8%
Q2 25
0.2%
3.3%
Q1 25
0.7%
2.4%
Q4 24
2.6%
Q3 24
0.6%
Q2 24
1.3%
3.3%
Cash Conversion
FRSH
FRSH
HCM
HCM
Q1 26
Q4 25
0.33×
4.21×
Q3 25
Q2 25
-0.16×
Q1 25
3.38×
Q4 24
Q3 24
Q2 24
-1.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons